Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening

Rohollah Nasiri; Yangzhi Zhu; Natan Roberto de Barros

doi:10.3390/bios14020086

Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening

Biosensors (Basel). 2024 Feb 4;14(2):86. doi: 10.3390/bios14020086.

Authors

Rohollah Nasiri¹, Yangzhi Zhu², Natan Roberto de Barros²

Affiliations

¹ Science for Life Laboratory, Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, 17165 Solna, Sweden.
² Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA.

Abstract

The convergence of microfluidics and organ-on-a-chip (OoC) technologies has revolutionized our ability to create advanced in vitro models that recapitulate complex physiological processes [...].

Publication types

Editorial

MeSH terms

Drug Evaluation, Preclinical
Lab-On-A-Chip Devices
Microfluidics*
Microphysiological Systems
Tissue Engineering*